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Abstract
Objective: To illustrate a new method for simplifying patient recruitment for advanced prostate cancer
clinical trials using natural language processing techniques. Background: The identification of eligible
participants for clinical trials is a critical factor to increase patient recruitment rates and an important
issue for discovery of new treatment interventions. The current practice of identifying eligible
participants is highly constrained due to manual processing of disparate sources of unstructured patient
data. Informatics-based approaches can simplify the complex task of evaluating patient’s eligibility
for clinical trials. We show that an ontology-based approach can address the challenge of matching
patients to suitable clinical trials. Methods: The free-text descriptions of clinical trial criteria as
well as patient data were analysed. A set of common inclusion and exclusion criteria was identified
through consultations with expert clinical trial coordinators. A research prototype was developed
using Unstructured Information Management Architecture (UIMA) that identified SNOMED CT
concepts in the patient data and clinical trial description. The SNOMED CT concepts model the
standard clinical terminology that can be used to represent and evaluate patient’s inclusion/exclusion
criteria for the clinical trial. Results: Our experimental research prototype describes a semi-automated
method for filtering patient records using common clinical trial criteria. Our method simplified the
patient recruitment process. The discussion with clinical trial coordinators showed that the efficiency
in patient recruitment process measured in terms of information processing time could be improved
by 25%. Conclusion: An UIMA-based approach can resolve complexities in patient recruitment for
advanced prostate cancer clinical trials.
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1 Introduction
There is always a strong need for better cancer treatment
options to find a cure, minimize the risks or prolong the
life of cancer suffers. Clinical trials offer an opportunity
for participation by cancer patients. They may result
in discovery of newer medications or treatment options
and thus it can improve the healthcare of cancer patients
[1]. However, it is widely reported that recruitment of
participants for clinical trials is a major factor in de-
laying new drug discovery and new treatments [2-5].
Operational delays in participant’s recruitment have a
negative impact on the medication patent exclusivity
time, commercial benefits and most importantly avail-
ability of treatment options. The healthcare benefits
strongly justify the need of any information technology
based efforts to minimize the delays in the clinical trial
process.
Our research shows that unstructured patient data
puts a computational challenge in automating the pa-
tient identification process fully or partially. The other
challenge in automating the process is that the data usu-
ally resides in disparate electronic or paper-based sys-
tems at various clinicians’ practices. This adds another
The electronic Journal of Health Informatics (ISSN:1446-4381) is dedicated to the advancement of Health Informatics and information technology in health
care. eJHI is an international Open Access journal committed to scholarly excellence and has a global readership in all health professions and at all levels.
c© Copyright of articles originally published in www.eJHI.net under the Creative Commons Attribution 3.0 License is retained by the authors.
Wagholikar et al. | electronic Journal of Health Informatics 2014; Vol 8(1):e6
layer of complexity in automating the patient identifica-
tion process. We propose an approach that can address
these challenges and provide a pragmatic solution for
improving efficiency in patient identification tasks. We
describe the application of our approach for advanced
prostate cancer clinical trials.
1.1 Background
1.1.1 Issues in patient recruitment
Identification of patients for advanced prostate cancer
clinical trials is a challenging task for clinicians as well
as clinical data custodians. The process of assessing suit-
ability of the patient against a clinical trial’s inclusion
and exclusion criteria is highly labor-intensive. The data
usually resides in disparate electronic or paper-based
systems both at Urologists and Oncologists. As a con-
sequence, the clinicians find it difficult to refer a patient
for a clinical trial and in some cases patients may not
have the opportunity to participate in a relevant clinical
trial. This may put certain limitations on the treatment
options of patients with advanced prostate cancer. The
inclusion and exclusion criteria for a clinical trial are
usually described in a free-text format. It is mostly
published in an un-structured format. There is also vari-
ability in describing inclusion and exclusion criteria for
each clinical trial. The investigators may describe the
same criteria differently. The complete automation of
the process of evaluating inclusion/exclusion criteria is
challenging due to variable and un-structured format
of the data. Some advances have recently been made
with web-based clinical trial finders [6]; however, this
requires manual review through a checklist of common
inclusion and exclusion criteria for each trial candidate
to assess their eligibility for a clinical trial.
The variability in clinical trial eligibility criteria can
be managed by mapping various semantically related
clinical terms to a standard set of clinical terminol-
ogy. We propose that Systematized Nomenclature of
Medicine – Clinical Terminology (SNOMED CT) can
be used to evaluate inclusion/exclusion criteria [7]. It
allows a consistent way to index, store, retrieve, and
aggregate clinical trial data. SNOMED CT also helps
organizing the content of medical records, reducing the
variability in the way data is captured, encoded and used
for clinical care of patients and research.
1.1.2 Existing State-of-the-art
There have been efforts made in developing computa-
tional methods for automating the clinical trial recruit-
ment process either fully or partially [8]. The level of
automation can be measured by the amount of manual
efforts required for a clinical trial coordinator to deter-
mine a patient suitable for the clinical trial. A fully
automated computational method means that all the
information processing tasks are automatically by the
system giving the final list of matching clinical trials to
the clinical trial coordinator. The approaches include
rule-based methods [9], query-based methods [9] and
Bayesian methods [10]. The final outcome of these
methods is to provide decision support to the clinicians
engaged in the patient recruitment process. The rule-
based methods use inference rules in “if-then” format
to identify eligible participants. These methods also
integrate the inference rules within the clinical work-
flow in order to identify any potential candidate for a
clinical trial [11, 12]. Some approaches suggest the ap-
plication automatic reasoner and description logic [13,
14]. The semantic approach proposed in these methods
certainly suggests automatic processing of patient and
clinical trial data [15]. The query-based methods search
a patient’s electronic health record (EHR) for identify-
ing specific conditions. These methods mainly propose
SQL-based queries to identify potential participants us-
ing their EHR stored in the hospital information system.
Some of these methods also propose a high level of
semantic abstraction and use of RDF and SPARQL lan-
guages.
However, our research shows that these methods are
not fully evaluated in a real-world setting and these
methods are used mainly only in research communities.
Our contribution to the research is a UIMA-MetaMap
based mechanism to annotate key clinical terminology
concepts in the text and a preliminary evaluation for a
real-world clinical trial setting. Our mechanism identi-
fies the value of the key inclusion criteria to filter out
patient records and thus minimize the delays in identify-
ing participants eligible for clinical trials. The novelty
of our approach lies in the software architectural frame-
work which proposes to annotate clinical trial descrip-
tions and patient data for common inclusion criteria
using Unstructured Information Management Architec-
ture (UIMA) [15] and Metamap [16, 17]. Metamap
is a widely used program for mapping clinical text to
concepts in Unified Medical Language System (UMLS).
UMLS is an overarching medical language system com-
prising of file and software that enables many health
and biomedical vocabularies and standards to interoper-
ate between various computerized clinical information
systems. SNOMED CT is one of the controlled vocabu-
laries of clinical terms embedded in UMLS. This work
is the extension of our work reported earlier [18]. The
earlier work reported about computational challenges
in developing patient matching algorithms for advanced
prostate cancer clinical trials.
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Common Inclusion Cri-
teria
Rules for extraction
ECOG Performance
Status
0-2
PSA Greater than 26
Diagnosis Progressive Prostate
Cancer
Gleason Score 3+3 or 8
Age Greater than 50
Sex Male
Table 1: Common Inclusion Criteria
2 Methods
This research describes an application of natural lan-
guage processing (NLP) techniques to determine patient
eligibility for advanced prostate cancer clinical trials.
The clinical data of advanced prostate cancer patients
is mostly in free-text form. It resides in radiology re-
port, pathology reports and clinician correspondence.
A clinical trial consists of inclusion and exclusion cri-
teria to determine eligibility of participants. We used
Java technologies [19] and a text-mining development
framework, namely, UIMA to demonstrate our approach.
UIMA is an architecture platform used to develop NLP-
based pipeline applications. We applied MetaMap to
map the clinical text to a SNOMED CT concept. We are
proposing an UIMA pipeline application for extracting
values of common inclusion and exclusion criteria from
the patient free-text.
3 Data Collection
The common criteria for advanced prostate cancer clin-
ical trials were identified through consultations with
clinical researchers and clinical trial coordinators. Ta-
ble 1 shows the common clinical trial criteria for the
advanced prostate cancer clinical trials.
The common exclusion criteria are highly specific
to a clinical trial. It is difficult and challenging task to
determine the common exclusion criteria. Therefore,
we show our approach using highly common inclusion
criteria. We identified an advanced prostate cancer clin-
ical trial through consultation with the clinical trial co-
ordinator at the Australian Prostate Cancer Research
Centre-Queensland (APCRC-Q). Sample patient data
were collected from a private urology clinic. The source
of the patient data was also determined through consulta-
tions with the clinical researchers. The data sources for
evaluating the patient eligibility were mostly radiology
and pathology investigations.
4 Data Processing
The common set of inclusion criteria shown in Table
1 was used to identify semantically equivalent clin-
ical information from the patient’s free text record.
That is, clinical concepts used to describe the inclu-
sion/exclusion criteria were used to test for occurrence
of clinical concepts identified in the free text. The fol-
lowing steps were performed to process the clinical
trials data as well as the patient data:
1. Process the clinical trials criteria text using UIMA
MetaMap framework.
2. Identify and extract the best matching SNOMED
CT concepts semantically related to the common
inclusion criteria as specified in Table 1.
3. Process the patient data using the UIMA-MetaMap
wrapper.
4. Identify and extract the common criteria and their
values.
5. Match the values of the concepts extracted in step
2 and step 4.
An aggregate score (Pat-Match score) resulting from
the inclusion/exclusion criteria matching process can be
used to identify or rank participants for possible enrol-
ment in clinical trials. This effectively automates the
short-listing of participants eligible for clinical trials,
whereby clinicians will be then able to evaluate the par-
ticipants for a given clinical trial. The UIMA-Metamap
wrapper was implemented to analyse the sample data.
Figure 1 shows the proposed application pipeline.
5 Results
The system outcomes are shown in Figure 2.
The common clinical inclusion criteria such as ECOG
Performance status is annotated by our system. The
other criteria such as PSA can be extracted from the
pathology investigation reports. The criteria such as age
and sex are not usually presented in the patient reports
but are easily extracted from patient metadata. Figure
2 shows that our proposed approach is able to annotate
key inclusion criteria. The patient records extracted
from a private urology clinic were manually analysed
to confirm the values of the annotations. For example,
the above annotation for ECOG in the clinical trial de-
scription was manually checked against the patient data.
The annotations helped in navigating large quantity of
clinical textual data in much lesser time than a complete
manual process.
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Figure 1: Proposed application pipeline
Figure 2: SNOMED CT annotations for sample clinical trial
inclusion criteria
Figure 3: UIMA Collection Processing Engine
6 Discussion
Our early experimental research shows that patient data
as well as clinical trial description data can be annotated.
The annotations using highly common inclusion criteria
for prostate cancer patients are a filtering mechanism to
identify potential participants eligible for clinical trials.
The evaluation of each and every mandatory criterion is
necessary for determining a participant’s eligibility. The
complete automation of each and every criterion is chal-
lenging as each criteria must have an acceptance value
for the clinician as well as the pharmaceutical company
conducing the trial. Our research shows that there is a
need of an individual annotator for every clinical trial
inclusion criterion. The annotators combined with a rule
or condition in the clinical trial criteria can improve the
efficiency in the overall patient evaluation process. The
implementation of our application pipeline in UIMA is
shown in Figure 3.
The proposed architecture was used to evaluate 84
advanced prostate cancer patients from a multidisci-
plinary team clinic (MDT) at a tertiary hospital. The
data for preliminary evaluation of our technology were
collected from the advanced prostate cancer patients.
The data collected were in a semi-structured format.
The patient data showed the values of common clinical
criteria specified in Table 1 in semi-structured format.
The patient data were used to identify eligible partic-
ipants for potential clinical trials being planned at an
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adult tertiary hospital. The execution of our proposed
mechanism and review by the clinical trial coordinator
showed that the sample size of 84 participants can be
reduced to potential 5 to 10 participants. These short-
listed participants can be further reviewed to evaluate
their eligibility. The main contribution of our proposed
mechanism is the filtering out ineligible patient records.
The filtering mechanism improves the efficiency in the
overall patient recruitment process. Specifically, our
mechanism is particularly very useful to the clinical
trial coordinators.
Our discussion with the clinical trial coordinators at
a tertiary hospital showed that the proposed mechanism
can improve the efficiency in patient identification. The
consultation with the clinical trial coordinators suggests
that at least 25 percentage of effort measured in time can
be saved if proposed mechanism in integrated within
the patient identification and recruitment process.
7 Limitations
The authors report the limitations encountered during
this research, which constrained the development of the
proposed computational approach. The authors could
not get sufficient sample size of advanced prostate can-
cer patient records to validate the proposed approach.
The advanced prostate cancer patient records were not
accessible in the required format to build NLP pipeline.
The authors also acknowledge lack of quantitative re-
sults and quantitative comparison for the proposed ap-
proach. The lack of quantitative comparison of the
results was mainly due to unavailability of baseline rep-
resentative sample of advanced prostate cancer patients.
The data set for advanced prostate cancer is mainly not
available for secondary use due to lack of data registries
for advanced prostate cancer in Australia and world-
wide. This is a well-known constraint among advanced
prostate cancer research community. This work presents
a baseline research that can build a foundation for build-
ing clinical text processing application pipelines.
8 Conclusion
The initial analysis of the patient data and active clinical
trials shows that the evaluation of participants using a
fully automated solution is a challenging task. A semi-
automated solution can be developed using inputs from
the clinicians. The computational approach will aim at
identifying a value of the inclusion/exclusion criteria
using the SNOMED CT terminology. Our proposed
text-mining and clinical terminology-based methods
can be used to further evaluate the patient data [20, 21].
Our proposed method can be useful when patient data is
coded to SNOMED CT in the source electronic health
record. It is anticipated that the proposed baseline solu-
tion will simplify the process of participant recruitment
for clinical trials.
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